Graeme Staley appointed to BOD

929 Mainland Street

Vancouver, BC V6B 1S3

Phone

Fax

(604) 928-8913

(604) 628-0129

Email [email protected]

Website www.lexston.ca

NEWS RELEASE

LEXSTON LIFE SCIENCES CORP. APPOINTS GRAEME STALEY TO ITS BOARD OF DIRECTORS

Vancouver, British Columbia, June 30, 2021. Lexston Life Sciences Corp. (CSE: LEXT) (the “Company” or

“Lexston”) is pleased to announce the appointment of Mr. Graeme Staley to its board of directors.

Mr. Staley is a founder of Purefarma Solutions Inc. and a Director of Heritage Cannabis Corp, a leading

cannabis products company operating two licensed manufacturing facilities in Canada, offering

innovative products to both the medical and recreational l egal cannabis markets in Canada and United

States. Mr. Staley has over 15 years of technical and management experience in design/build mechanical

contracting and engineering.

“Lexston is quickly growing its team of business and clinical professionals th at will lead us in our pursuit

to create a synergy between plants, people and processes to heal others through the use of Psychedelics.”

states Jag Bal, Chief Executive Officer of Lex ston. “ The addition of Mr. Staley to our board will be a

tremendous asset to the company and our goal to be a leader in the world of health and wellness.”.

About Lexston Life Sciences Corp.

Lexston Life Sciences Corp. is a Canadian biotechnology company providing cannabis testing and research

services. Lexston is also in the process of securing licensing under the exemptions prescribed by section

56 of the Controlled Drugs and Substances Act (Canada) to enable the expansion of its services into the

psychedelic industry with an initial focus on the detection and quantification of psychedelic molecules in

the lab and point of care. Lexston intends to develop and validate methods for standardized

manufacturing of plant derived psychedelics in support of burgeoning trials in the field of mental health

and wellness.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal, Chief Executive Officer

Telephone: (604) 928-8913

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for

the adequacy or accuracy of this release.